{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:53:28Z","timestamp":1792518808126,"version":"4.5.0"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2020-11-3","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T11:14:58Z","timestamp":1610968498000},"page":"1-29","source":"Crossref","is-referenced-by-count":32,"title":["Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review"],"prefix":"10.7573","volume":"10","author":[{"given":"Xenophon","family":"Kassianides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2021,1,18]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2021\/01\/dic-2020-11-3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T11:14:59Z","timestamp":1610968499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/hypophosphataemia,-fibroblast-growth-factor-23,-and-third-generation-intravenous-iron-compounds:-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2020-11-3","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]}}}